imatinib mesylate has been researched along with Hepatitis, Autoimmune in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I | 1 |
| Aglietta, M; Aliberti, S; Allione, P; Fizzotti, M; Galatola, G; Grignani, G; Pisacane, A | 1 |
| Besson, C; Buffet, C; Dhalluin-Venier, V; Dimet, S; Tchernia, G; Thirot-Bibault, A | 1 |
| Al Sobhi, E; Zahrani, Z; Zevallos, E; Zuraiki, A | 1 |
4 other study(ies) available for imatinib mesylate and Hepatitis, Autoimmune
| Article | Year |
|---|---|
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin | 2022 |
An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
Topics: Acute Disease; Aged; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Gastrointestinal Stromal Tumors; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2009 |
Imatinib mesylate-induced acute hepatitis with autoimmune features.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Benzamides; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Function Tests; Piperazines; Polyethylene Glycols; Prednisone; Pyrimidines; Recombinant Proteins | 2006 |
Imatinib-induced immune hepatitis: case report and literature review.
Topics: Adolescent; Alanine Transaminase; Antibodies, Antinuclear; Antibody Specificity; Antineoplastic Agents; Aspartate Aminotransferases; Autoantibodies; Autoantigens; Benzamides; DNA; Female; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Immunosuppressive Agents; Jaundice, Obstructive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Muscle, Smooth; Piperazines; Prednisolone; Pyrimidines | 2007 |